Video Experimental Relacionado
Updated: Jul 13, 2026
09:41
Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery
Published on: December 23, 2014
La sobreexpresión de la trombomodulina para limitar la formación de neointima
J M Waugh1, J Li-Hawkins, E Yuksel
1Department of Cell Biology, Baylor College of Medicine, Houston, Tex.
Circulation
|July 19, 2000
Resumen
La sobreexpresión de trombomodulina de alto nivel limita efectivamente la formación de neointima después de una lesión arterial. Este vector adenoviral (Adv / RSV-THM) reduce la inflamación y el trombo, preservando la matriz de los vasos para la reparación de las arterias.
Área de la Ciencia:
- Biología Vascular Biología Vascular
- Terapia génica Terapia génica La terapia génica es una terapia genética.
- Investigación Cardiovascular Investigación Cardiovascular Investigación Cardiovascular Investigación Cardiovascular Investigación Cardiovascular
Sus antecedentes:
- La formación de neointima es un factor clave en la remodelación vascular posterior a la lesión.
- La trombomodulina juega un papel crucial en la regulación de la coagulación y la inflamación.
- Estudios previos sugieren el potencial de la trombomodulina para limitar la hiperplasia vascular.
Objetivo del estudio:
- Para confirmar si la sobreexpresión de trombomodulina de alto nivel puede prevenir la formación de neointima después de una lesión mecánica.
- Para evaluar la eficacia de un vector adenoviral que libera trombomodulina (Adv / RSV-THM) en un modelo de conejo.
Principales métodos:
- Se desarrolló y probó un constructo adenoviral (Adv/RSV-THM) in vitro e in vivo.
- Los conejos blancos de Nueva Zelanda sufrieron una lesión de sobredilatación mecánica en las arterias femorales.
- Las arterias fueron tratadas con amortiguador, control viral o Adv / RSV-THM y analizadas después de 28 días para las relaciones intima-media.
Principales resultados:
- Adv / RSV-THM redujo significativamente la formación de neointima (relación I / M 0.47) en comparación con los controles (0.76-0.77).
- Los primeros análisis mostraron una disminución de la inflamación local, la formación de trombos y la matriz preservada en el grupo Adv / RSV-THM.
- La construcción demostró la caracterización funcional in vitro e in vivo.
Conclusiones:
- La sobreexpresión de trombomodulina mediada por adenovirales es suficiente para limitar la formación de neointima.
- Adv/RSV-THM ofrece una estrategia viable para crear arterias resistentes al neointima.
- Este enfoque minimiza el daño inflamatorio asociado con las aplicaciones adenovirales.
Videos de Conceptos Relacionados
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.